Thus, NAMPT could be an effective therapeutic target for preventing and treating metabolic disorders, including obesity and type 2 diabetes mellitus, inflammation, and cancer [74]. This evidence concerns the gene NAMPT and obesity due to melanocortin 4 receptor deficiency.